Work

Scheduled administration of low dose irinotecan before gemcitabine in the second line therapy of non-small cell lung cancer: a phase II study

Year: 2008

Type: article

Study design: Clinical Trial

Source: Anti-Cancer Drugs

DOI: 10.1097/cad.0b013e328301c54f

Authors: Nithya Ramnath, Jihnhee Yu, Nikhil I. Khushalani, Ronald H. Gottlieb, James K. Schwarz, Renuka V. Iyer, Youcef M. Rustum, Patrick J. Creaven

Institutions: Roswell Park Comprehensive Cancer Center, Nebraska Medical Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2045335497

FWCI: 0.556

Cites: 22

Cited by: 4

Related to: 10